BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30874290)

  • 1. Tobacco Cost of Illness Studies: A Systematic Review.
    Makate M; Whetton S; Tait RJ; Dey T; Scollo M; Banks E; Norman R; Pidd K; Roche AM; Allsop S
    Nicotine Tob Res; 2020 Apr; 22(4):458-465. PubMed ID: 30874290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of tobacco-related diseases, including passive smoking, in Hong Kong.
    McGhee SM; Ho LM; Lapsley HM; Chau J; Cheung WL; Ho SY; Pow M; Lam TH; Hedley AJ
    Tob Control; 2006 Apr; 15(2):125-30. PubMed ID: 16565461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic impact of tobacco smoking and secondhand smoke exposure in Jordan: estimating the direct and indirect costs.
    Alkhatib NS; Massad E; Rashdan O; Max W; Halloush S; Abumansour H; Alkhatib A; Karasneh RA; Al-Shatnawi S; Qirim T; Hawari F; Alkhatib S
    J Med Econ; 2024; 27(1):880-886. PubMed ID: 38923934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of smoking in China, 2000.
    Sung HY; Wang L; Jin S; Hu TW; Jiang Y
    Tob Control; 2006 Jun; 15 Suppl 1(Suppl 1):i5-11. PubMed ID: 16723677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Economic Cost of Smoking in South Africa, 2016.
    Boachie MK; Rossouw L; Ross H
    Nicotine Tob Res; 2021 Jan; 23(2):286-293. PubMed ID: 32832993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The healthcare costs of secondhand smoke exposure in rural China.
    Yao T; Sung HY; Mao Z; Hu TW; Max W
    Tob Control; 2015 Oct; 24(e3):e221-6. PubMed ID: 25335898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Costs Attributable to Smoking in Hong Kong in 2011: A Possible Increase From 1998.
    Chen J; McGhee S; Lam TH
    Nicotine Tob Res; 2019 Mar; 21(4):505-512. PubMed ID: 29149286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluations of smoking cessation and relapse prevention programs for pregnant women: a systematic review.
    Ruger JP; Emmons KM
    Value Health; 2008; 11(2):180-90. PubMed ID: 17854435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Costs of Diseases and Deaths Attributable to Tobacco Use in India, 2017-2018.
    John RM; Sinha P; Munish VG; Tullu FT
    Nicotine Tob Res; 2021 Jan; 23(2):294-301. PubMed ID: 32805055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic cost of preventable disease in Australia: a systematic review of estimates and methods.
    Crosland P; Ananthapavan J; Davison J; Lambert M; Carter R
    Aust N Z J Public Health; 2019 Oct; 43(5):484-495. PubMed ID: 31390112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of adult chronic rhinosinusitis: A systematic review.
    Smith KA; Orlandi RR; Rudmik L
    Laryngoscope; 2015 Jul; 125(7):1547-56. PubMed ID: 25640115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The financial impact of smoking on health-related costs: a review of the literature.
    Max W
    Am J Health Promot; 2001; 15(5):321-31. PubMed ID: 11502013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global economic cost of smoking-attributable diseases.
    Goodchild M; Nargis N; Tursan d'Espaignet E
    Tob Control; 2018 Jan; 27(1):58-64. PubMed ID: 28138063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the tobacco settlement damage awards: too much or not enough?
    Coller M; Harrison GW; McInnes MM
    Am J Public Health; 2002 Jun; 92(6):984-9. PubMed ID: 12036793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review.
    Zemedikun DT; Kigozi J; Wynne-Jones G; Guariglia A; Roberts T
    PLoS One; 2021; 16(5):e0251406. PubMed ID: 33974661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.
    Mac S; da Silva SR; Sander B
    PLoS One; 2019; 14(1):e0210280. PubMed ID: 30608986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(45):1226-8. PubMed ID: 19008791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco and children. An economic evaluation of the medical effects of parental smoking.
    Aligne CA; Stoddard JJ
    Arch Pediatr Adolesc Med; 1997 Jul; 151(7):648-53. PubMed ID: 9232036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia.
    Ganasegeran K; Hor CP; Jamil MFA; Loh HC; Noor JM; Hamid NA; Suppiah PD; Abdul Manaf MR; Ch'ng ASH; Looi I
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.